Lixin Zhang-Auberson

Statistics

Publications

Citations

3.6K

H-Index

Active since

2010

Affiliations

Novartis (Switzerland)(Current)

University Hospital of Basel

St. Michael's Hospital

Novartis (United States)

Medical University of Lodz

Lixin Zhang-Auberson is an author at Novartis (Switzerland) specializing in fingolimod therapy, relapsing-remitting multiple sclerosis treatment, and multiple sclerosis therapy.

Publications per year

2010–2015

Publications

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Ludwig Kappos, Ernst‐Wilhelm Radue, Paul O’Connor et al. · New England Journal of Medicine · 2010 · 2.6K citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study

Bhupendra Khatri, Frederik Barkhof, Giancarlo Comi et al. · The Lancet Neurology · 2011 · 216 citations · Full text

Life Sciences, Neurology, Neuroimmunology +8

Long-term effects of fingolimod in multiple sclerosis

Ludwig Kappos, Paul O’Connor, Ernst‐Wilhelm Radue et al. · Neurology · 2015 · 189 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +14

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

V. Devonshire, Eva Havrdová, Ernst W. Radue et al. · The Lancet Neurology · 2012 · 182 citations

Medicine, Neurology, Disability Management +12

Fingolimod in relapsing multiple sclerosis: An integrated analysis of safety findings

Ludwig Kappos, Jeffrey A. Cohen, William Collins et al. · Multiple Sclerosis and Related Disorders · 2014 · 117 citations

Life Sciences, Neurology, Neurodegeneration +9

1–5 of 10